Psylink logo
VerifiedBiotechnology Research· Founded 2020

Psylink

We are developing a new class of targeted psychedelic agents to selectively intervene with serotonin receptors. Using synthetic biology, genome engineering tools we create well-known and new psychedelic derivatives used in preclinical and clinical research to eradicate most debilitating mental health disorders.

7-day free trial · no credit card

HeadquartersVilnius, LithuaniaEmployees5(1 to 10)Founded year2020Websitepsylink.ioLinkedIn profileLinkedIn

Verified contacts

1

available on Kipplo

LinkedIn employees

5

1 to 10 range

Open roles

no listings

Distinct roles

1

indexed titles

Tech stack

0

tools in use

Monthly traffic

organic / mo

Sign up free to see all 1 verified contacts at Psylink

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

1 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 1 of 1 verified contacts

Top roles at Psylink

1 distinct titles indexed · top 1 shown.

  • 1co-founder and ceo

Sign up to unlock all 1 contacts at Psylink

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 1 verified contacts at Psylink

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Psylink | Kipplo Discover